Silvia Moreira Ayub‐Ferreira

Author

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo ORCID

Also Known As

Ayub-Ferreira, Silvia Moreira, FERREIRA, Silvia Moreira Ayub, Ines Silva, Instituto do Coração - FMUSP Unidade de Insuficiência Cardíaca –. São Paulo, SP, Brasil., Isabel Ferreira, Max Senna Mano, Mário Ferraz, Philip St John, S M A F Silvia Moreira Ayub Ferreira, S M Ayub-Ferreira

157

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Universidade de São Paulo Instituto Dante Pazzanese de Cardiologia Hospital Universitário da Universidade de São Paulo St. James's Hospital

About

Silvia Moreira Ayub‐Ferreira is an author at Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	860
2	Public Health	4	4	64
3	Health Sciences	3	3	82
4	Engineering	1	1	33
5	Applied Physiology	1	1	47

Silvia Moreira Ayub‐Ferreira

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity Mônica Samuel Ávila, Silvia Moreira Ayub‐Ferreira, Mauro Rogério de Barros Wanderley, Journal of the American College of Cardiology Cardiorenal SyndromesCardiovascular DiseaseMedicineChemotherapy-related CardiotoxicityPharmacotherapy	2018	474
III Diretriz Brasileira de Insuficiência Cardíaca Crônica Edimar Alcides Bocchi, Fabiana G. Marcondes‐Braga, Silvia Moreira Ayub‐Ferreira, Americanae (AECID Library)	2012	169
Long-Term Prospective, Randomized, Controlled Study Using Repetitive Education at Six-Month Intervals and Monitoring for Adherence in Heart Failure Outpatients Edimar Alcides Bocchi, Fátima das Dores Cruz, Guilherme Veiga Guimarães, Circulation Heart Failure	2008	124
Circulating miR-1 as a potential biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients Vagner Oliveira Carvalho Rigaud, Ludmila Rodrigues Pinto Ferreira, Silvia Moreira Ayub‐Ferreira, Oncotarget	2016	117
β-Blocker Therapy and Mortality of Patients With Chagas Cardiomyopathy Victor Sarli Issa, Alexandre Franco Amaral, Fátima das Dores Cruz, Circulation Heart Failure	2009	100
Exhaled Acetone as a New Biomarker of Heart Failure Severity Fabiana G. Marcondes‐Braga, Ivano Gebhardt Rolf Gutz, Guilherme Lopes Batista, CHEST Journal Heart FailureCardiovascular DiseasePhysiologyPulmonary PharmacologyExhaled Acetone	2012	97
Zika Virus Meningoencephalitis in an Immunocompromised Patient Pedro Vellosa Schwartzmann, Leandra Náira Zambelli Ramalho, Luciano Neder, Mayo Clinic Proceedings VaccinationImmunologyVirologyMedicineZika Virus Meningoencephalitis	2017	77
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19 Christiana Kartsonaki, J. Kenneth Baillie, Noelia García Barrio, International Journal of Epidemiology	2023	68
Mode of Death on Chagas Heart Disease: Comparison with Other Etiologies. A Subanalysis of the REMADHE Prospective Trial Silvia Moreira Ayub‐Ferreira, Sandrigo Mangini, Victor Sarli Issa, PLoS neglected tropical diseases	2013	62
Hypertonic saline solution for prevention of renal dysfunction in patients with decompensated heart failure Victor Sarli Issa, Lúcia Andrade, Silvia Moreira Ayub‐Ferreira, International Journal of Cardiology Heart FailureRenal FunctionDecompensated Heart FailureHypertonic Saline SolutionMedicine	2012	57

Page 1